| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/13/2000 | WO2000040561A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040261A2 Vaccination method for efficient induction of cytotoxic t lymphocyte response |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040242A2 Preparation of a composition against hepatitis b-, hi-, paramyxo- and orthomyxoviruses |
| 07/13/2000 | WO2000040241A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | WO2000040239A1 Compounds and methods |
| 07/13/2000 | WO2000040237A1 Antiviral method using mek inhibitors |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000040225A2 Inhibition of tnf activity |
| 07/13/2000 | WO2000040217A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000027363B1 Aerosols comprising nanoparticle drugs |
| 07/13/2000 | WO2000019976A3 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/13/2000 | WO2000018433A3 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
| 07/13/2000 | WO2000015256A3 Immunostimulant emulsion |
| 07/13/2000 | WO2000015208A3 New use of immunosupressants for mmp-mediated diseases |
| 07/13/2000 | WO2000014217A3 G-motif oligonucleotides and uses thereof |
| 07/13/2000 | WO2000012128A3 Recombinant subunit vaccine against flaviviral infection |
| 07/13/2000 | WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof |
| 07/13/2000 | WO2000009734A9 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 07/13/2000 | WO1999058096A9 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 07/13/2000 | WO1999055162A8 Method for the treatment of viral disease |
| 07/13/2000 | WO1999053950A9 Live vaccines and methods of treatment therewith |
| 07/13/2000 | DE19933939A1 Ausnutzung zelleigener Transportsysteme zum Transfer von Nukleinsäuren durch die Kernhülle Utilization of cellular transport systems for the transfer of nucleic acids by the nuclear envelope |
| 07/13/2000 | DE19917838A1 Composition for treating prion or other neurodegenerative diseases, comprises a peptide that inhibits unfolding of the prion to its pathological isoform |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | DE19900503A1 Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit Use of a composition for the manufacture of a medicament for the treatment of diseases with increased extracellular FasL titers method for the prophylactic or suitability quality control thereof, a process for the preparation of medicaments for the treatment of the above diseases with enhanced efficacy |
| 07/13/2000 | DE19847074C1 Verfahren zum Entfernen von Lipopolysacchariden aus wäßrigen, proteinhaltigen Lösungen A method for removing lipopolysaccharides from aqueous, protein-containing solutions |
| 07/13/2000 | CA2778317A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2358851A1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | CA2358594A1 Novel derivatives from the class of oleandomycin |
| 07/13/2000 | CA2358570A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | CA2358438A1 Antiviral method using mek inhibitors |
| 07/13/2000 | CA2358119A1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | CA2357996A1 Streptococcal abc transporter protein |
| 07/13/2000 | CA2357986A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | CA2357950A1 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | CA2357874A1 Cyclic compound |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | CA2353636A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | CA2353634A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/12/2000 | EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 07/12/2000 | EP1018556A1 Chimeric and/or growth-restricted flaviviruses |
| 07/12/2000 | EP1018555A2 Chimeric papilomavirus-like particles |
| 07/12/2000 | EP1018517A2 Binding agents to CD23 for treatment of inflammatory, autoimmune or allergic diseases |
| 07/12/2000 | EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes |
| 07/12/2000 | EP1018342A2 Diagnosis and treatment of bacterial dysentery |
| 07/12/2000 | EP1018337A2 Formulations containing chlorhexidine, novel chlorhexidine salts,solutions containing the aforesaid chlorhexidine salts and their use |
| 07/12/2000 | EP1017980A2 Methods of the identification of pharmaceutically active compounds |
| 07/12/2000 | EP1017854A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors |
| 07/12/2000 | EP1017823A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/12/2000 | EP1017727A1 Composition and pharmaceutical preparation containing same for the treatment of herpes and related viral infections |
| 07/12/2000 | EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 07/12/2000 | EP1017714A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 07/12/2000 | EP1017706A1 Cyclic phosphites and phosphates |
| 07/12/2000 | EP1017697A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 07/12/2000 | EP1017692A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 07/12/2000 | EP1017672A1 New npy antagonists |
| 07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2000 | EP1017418A1 Vaccine composition for preventing or treating c hepatitis |
| 07/12/2000 | EP1017417A1 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION FOR USE BY THE SUBDIAPHRAGMATIC SYSTEMIC ROUTE, AND COMBINED MUCOSAL/PARENTERAL IMMUNIZATION METHOD |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP1017401A2 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid a |
| 07/12/2000 | EP1017397A1 Photosensitizer conjugates for pathogen targeting |
| 07/12/2000 | EP1017392A1 Medicament formulation with a controlled release of an active agent |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP1017283A1 Polynucleotide vaccine formulations |
| 07/12/2000 | EP1017278A2 Use of quaternary carboxylic acid alkanolamine ester salts as microbicide agents |
| 07/12/2000 | EP0789754B1 H. pylori fermentation process |
| 07/12/2000 | EP0642342B1 Selective cell inactivation in blood |
| 07/12/2000 | EP0561850B1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 07/12/2000 | EP0550553B1 Viral defective vaccine produced by transcomplementing cell line |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1260000A Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 07/12/2000 | CN1259960A Vaccine compositions comprising the helicobacter pylori FlgE polypeptide |
| 07/12/2000 | CN1259955A C-4'-substituted macrolide derivatives |
| 07/12/2000 | CN1259952A Carbostyril carboxylic acid derivatives |
| 07/12/2000 | CN1259951A Novel pharmaceutically useful compounds |
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259874A Vaginal lactobacillus medicant |
| 07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
| 07/12/2000 | CN1259867A Use of bis-1,2,4-triazoles for mfg. medicament for treating cancers |
| 07/12/2000 | CN1259864A Rapamycin formulations for oral administration |
| 07/12/2000 | CN1259522A Novel protain from lobar pneumonia Actinomyces |
| 07/12/2000 | CN1259517A Method for preparing 2,5-diamino-4,6-dichloropyrimidine |
| 07/12/2000 | CN1259386A Isoniazid synergistic compound aerosol and its prepn. method |
| 07/12/2000 | CN1259351A Infant fetal toxin ointment |
| 07/12/2000 | CN1259347A Polyether medicine used for antituberculosis and antileprosy |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |
| 07/12/2000 | CN1259285A Disinfectant powder for feet and its preparing method |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087374 Anti-viral compounds |